Moreover, chronic inflammation (as assessed by different biomarkers such as proinflammatory adipokine, leptin, and/or proinflammatory cytokines IL-6 and IL-1β) has been described to play a crucial role in the development of metabolic disease. Here, IL1B is linked to metabolic disease.